ArticleNature communications2026
Pyridium-π interaction preserves N,S-benzylidene thioacetals in acidolysis enabling efficient protein chemical synthesis.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Silver(I)-mediated amide-to-ester transformation on unprotected peptides for protein chemical synthesis and engineering.Science advances · 2026Article
- Site-Specific and Programmable Editing of Serine and Threonine in Unprotected Peptides.Journal of the American Chemical Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Chemical protein synthesis provides the atomic-level precision to access peptides and proteins, yet the synthesis of aggregation-prone one remains a major challenge. Here, we report the picolinoylated N,S-benzylidene thioacetal dipeptides (NTDs) strategy to facilitate the chemical synthesis of difficult peptides and proteins. NTDs can serve as an effective aggregation disruptor and be robustly prepared in high yield, which can be rapidly introduced through standard solid-phase peptide synthesis (SPPS). Furthermore, we discover a picolinoylation-based strategy to address the acid lability of NTDs, which preserves the scaffold during global deprotection through pyridium-π interaction and can be selectively removed on demand. This approach effectively suppresses aggregation both on-resin and in-solution, facilitates macrocyclization, and permits selective manipulation of cysteine residues during multi-fragment assembly. As a demonstration, we achieve the chemical synthesis of the hydrophobic protein human erythropoietin (hEPO) via a convergent route with native chemical ligation and serine/threonine ligation incorporating the NTD chemistry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.